Results
|
1.
|
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry). MedStar authors:
Year: 2012
Citation: - American Journal of Cardiology. 110(3):350-5, 2012 Aug 1.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bach RG, Caputo RP, Cohen DJ, Dhar G, Goel A, Gordon P, Kleiman NS, Lopez JJ, Pencina M, Tolerico P, Waksman R, Yen CH
|
|
2.
|
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. MedStar authors:
- Waksman, Ron
- Weissman, Neil J
Year: 2013
Citation: - Lancet. 381(9869):836-44, 2013 Mar 9.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Bose D, Degen H, Erbel R, Erne P, Haude M, Koolen J, Prati F, Verheye S, Vermeersch P, Waksman R, Weissman N, Wijnbergen I
|
|
3.
|
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2017
Citation: - Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
|
|
4.
|
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Jacc: Cardiovascular Interventions. 15(18):1852-1860, 2022 Sep 26.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
5.
|
Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Catheterization & Cardiovascular Interventions. 92(7):E502-E511, 2018 Dec 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Abizaid A, Alves Lemos P, Barbato E, BIOSOLVE-II and III investigators, Christiansen EH, Garcia-Garcia HM, Haude M, Ince H, Kische S, Tolg R, Van Mieghem NM, Verheye S, von Birgelen C, Waksman R
|
|
6.
|
Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound. MedStar authors:
- Chen, Fang
- Kitabata, Hironori
- Loh, Joshua P
- Magalhaes, Marco A
- Minha, Sa'ar
- Omar, Alfazir
- Ota, Hideaki
- Pendyala, Lakshmana K
- Pichard, Augusto D
- Satler, Lowell F
- Torguson, Rebecca
- Waksman, Ron
Citation: - Cardiovascular Revascularization Medicine. 15(3):149-55, 2014 Apr.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Observational Study
All authors: - Chen F, Kitabata H, Loh JP, Magalhaes MA, Minha S, Omar A, Ota H, Pendyala LK, Pichard AD, Satler LF, Torguson R, Waksman R
|
|
7.
|
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2020
Citation: - Jacc: Cardiovascular Interventions. 13(11):1343-1353, 2020 06 08.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
8.
|
Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial. MedStar authors:
- Loh, Joshua P
- Torguson, Rebecca
- Waksman, Ron
Citation: - Cardiovascular Revascularization Medicine. 15(1):23-8, 2014 Jan.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
All authors: - Loh JP, Sangiorgi G, Silber S, Stahnke S, Stella PR, Torguson R, von Strandmann RP, Waksman R
|
|
9.
|
Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial. MedStar authors:
- Bastian, Roshni
- Chandra, Nina
- Garcia-Garcia, Hector M
- Leiboff, Roy
- Spad, Mia-Ashley
- Torguson, Rebecca
- Waksman, Ron
- Wang, John
Year: 2017
Citation: - Cardiovascular Revascularization Medicine. 18(7):475-481, 2017 Oct - Nov.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Southern Maryland Hospital Center
- MedStar Union Memorial Hospital
Medline publication type:
All authors: - Adams G, Bastian R, Cannon L, Chandra N, DeGroot J, Garcia-Garcia HM, Kabour A, Kayo MW, Kereiakes DJ, Leiboff R, Piegari GN, Smeglin A, Solankhi N, Spad MA, Stoll HP, Torguson R, Waksman R, Wang J
|
|
10.
|
Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). MedStar authors:
Year: 2012
Citation: - The International Journal of Cardiovascular Imaging. 28(3):455-65, 2012 Mar.
Institution: - MedStar Health Research Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - APPROACH study group, Brugaletta S, Garcia-Garcia HM, Garg S, Huang C, Kolatkar NS, Kravitz BG, Miller DM, Morocutti G, Nesto RW, Ratner RE, Serruys PW
|
|
11.
|
Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents. MedStar authors:
- Kitabata, Hironori
- Laynez-Carnicero, Ana
- Loh, Joshua P
- Pichard, Augusto D
- Sardi, Gabriel L
- Satler, Lowell F
- Torguson, Rebecca
- Waksman, Ron
- Xue, Zhenyi
Year: 2014
Citation: - Cardiovascular Revascularization Medicine. 15(2):86-91, 2014 Mar.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
All authors: - Kitabata H, Laynez-Carnicero A, Loh JP, Pichard AD, Sardi GL, Satler LF, Torguson R, Waksman R, Xue Z
|